| Heart disease and stroke statistics—2020 update: a report from the American Heart Association SS Virani, A Alonso, EJ Benjamin, MS Bittencourt, CW Callaway, ... Circulation 141 (9), e139-e596, 2020 | 18391* | 2020 |
| A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth S Bonnet, SL Archer, J Allalunis-Turner, A Haromy, C Beaulieu, ... Cancer cell 11 (1), 37-51, 2007 | 1994 | 2007 |
| Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives M Humbert, C Guignabert, S Bonnet, P Dorfmüller, JR Klinger, MR Nicolls, ... European Respiratory Journal 53 (1), 2019 | 1185 | 2019 |
| An abnormal mitochondrial–hypoxia inducible factor-1α–Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities … S Bonnet, ED Michelakis, CJ Porter, MA Andrade-Navarro, B Thébaud, ... Circulation 113 (22), 2630-2641, 2006 | 683 | 2006 |
| Role for miR-204 in human pulmonary arterial hypertension A Courboulin, R Paulin, NJ Giguère, N Saksouk, T Perreault, J Meloche, ... Journal of Experimental Medicine 208 (3), 535-548, 2011 | 628 | 2011 |
| Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis MS McMurtry, S Bonnet, X Wu, JRB Dyck, A Haromy, K Hashimoto, ... Circulation research 95 (8), 830-840, 2004 | 575 | 2004 |
| Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats T van Haaften, R Byrne, S Bonnet, GY Rochefort, J Akabutu, ... American journal of respiratory and critical care medicine 180 (11), 1131-1142, 2009 | 504 | 2009 |
| Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension MS McMurtry, SL Archer, DC Altieri, S Bonnet, A Haromy, G Harry, ... The Journal of clinical investigation 115 (6), 1479-1491, 2005 | 486 | 2005 |
| The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted S Bonnet, G Rochefort, G Sutendra, SL Archer, A Haromy, L Webster, ... Proceedings of the National Academy of Sciences 104 (27), 11418-11423, 2007 | 458 | 2007 |
| Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis AC Lajoie, G Lauzière, JC Lega, Y Lacasse, S Martin, S Simard, S Bonnet, ... The lancet Respiratory medicine 4 (4), 291-305, 2016 | 294 | 2016 |
| Role for DNA damage signaling in pulmonary arterial hypertension J Meloche, A Pflieger, M Vaillancourt, R Paulin, F Potus, S Zervopoulos, ... Circulation 129 (7), 786-797, 2014 | 278 | 2014 |
| Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension G Sutendra, S Bonnet, G Rochefort, A Haromy, KD Folmes, ... Science translational medicine 2 (44), 44ra58-44ra58, 2010 | 272 | 2010 |
| Preferential Expression and Function of Voltage-Gated, O2-Sensitive K+ Channels in Resistance Pulmonary Arteries Explains Regional Heterogeneity in Hypoxic … SL Archer, XC Wu, B Thébaud, A Nsair, S Bonnet, B Tyrrell, MS McMurtry, ... Circulation research 95 (3), 308-318, 2004 | 261 | 2004 |
| The role of Nogo and the mitochondria–endoplasmic reticulum unit in pulmonary hypertension G Sutendra, P Dromparis, P Wright, S Bonnet, A Haromy, Z Hao, ... Science translational medicine 3 (88), 88ra55-88ra55, 2011 | 248 | 2011 |
| Sirtuin 3 Deficiency Is Associated with Inhibited Mitochondrial Function and Pulmonary Arterial Hypertension in Rodents and Humans R Paulin, P Dromparis, G Sutendra, V Gurtu, S Zervopoulos, L Bowers, ... cell metabolism, 2014 | 235 | 2014 |
| Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury F Ladha, S Bonnet, F Eaton, K Hashimoto, G Korbutt, B Thébaud American journal of respiratory and critical care medicine 172 (6), 750-756, 2005 | 226 | 2005 |
| Downregulation of microRNA-126 contributes to the failing right ventricle in pulmonary arterial hypertension F Potus, G Ruffenach, A Dahou, C Thebault, S Breuils-Bonnet, ... Circulation 132 (10), 932-943, 2015 | 225 | 2015 |
| Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension S Bonnet, SL Archer Pharmacology & therapeutics 115 (1), 56-69, 2007 | 211* | 2007 |
| The cancer theory of pulmonary arterial hypertension O Boucherat, G Vitry, I Trinh, R Paulin, S Provencher, S Bonnet Pulmonary circulation 7 (2), 285-299, 2017 | 208 | 2017 |
| Potassium channel subfamily K member 3 (KCNK3) contributes to the development of pulmonary arterial hypertension F Antigny, A Hautefort, J Meloche, M Belacel-Ouari, B Manoury, ... Circulation 133 (14), 1371-1385, 2016 | 204 | 2016 |
Olivier BoucheratZweryfikowany adres z criucpq.ulaval.ca
